To Boost Or Not To Boost? Pfizer At Odds With US FDA

Pfizer Unphased By Apparent Pushback

 
• By Andrew McConaghie
US vaccination centre
Despite a rapid uptake from some US adults, so far only 54% have received at least one vaccine dose.

More from Business

More from Scrip